GS
Gilead Sciences Portfolio holdings
AUM
$1.28B
This Quarter Return
-5.89%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.55B
AUM Growth
–
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.28%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Arcellx
ACLX
|
$515M |
| 2 |
Galapagos
GLPG
|
$462M |
| 3 |
Arcus Biosciences
RCUS
|
$448M |
| 4 |
Assembly Biosciences
ASMB
|
$34.9M |
| 5 |
Merus
MRUS
|
$19M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcellx
ACLX
$3.85B
| $515M | 33.23% | +6,720,803 | New | +$515M |
|
|
2
Galapagos
GLPG
$2.07B
| $462M | 29.77% | +16,707,477 | New | +$462M |
|
|
3
Arcus Biosciences
RCUS
$1.13B
| $448M | 28.86% | +30,061,124 | New | +$448M |
|
|
4
Assembly Biosciences
ASMB
$190M
| $34.9M | 2.25% | +2,209,471 | New | +$34.9M |
|
|
5
Merus
MRUS
$4.98B
| $19M | 1.23% | +452,527 | New | +$19M |
|
6
Kyverna Therapeutics
KYTX
$160M
| $15.4M | 0.99% | +4,126,119 | New | +$15.4M |
|
7
Leap Therapeutics
LPTX
$12M
| $15.3M | 0.99% | +5,319,148 | New | +$15.3M |
|
8
Tango Therapeutics
TNGX
$747M
| $15M | 0.97% | +4,854,443 | New | +$15M |
|
9
Xilio Therapeutics
XLO
$36.3M
| $8.7M | 0.56% | +9,105,451 | New | +$8.7M |
|
|
KLRS
10
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $6.99M | 0.45% | +16,635,286 | New | +$6.99M |
|
|
HOOK
11
DELISTED
HOOKIPA Pharma
HOOK
| $3.77M | 0.24% | +1,875,945 | New | +$3.77M |
|
|
IMA
12
ImageneBio, Inc. Common Stock
IMA
$150M
| $3.29M | 0.21% | +2,008,338 | New | +$3.29M |
|
13
Allogene Therapeutics
ALLO
$251M
| $2.46M | 0.16% | +1,156,689 | New | +$2.46M |
|
|
BRNS
14
Barinthus Biotherapeutics
BRNS
$45.6M
| $749K | 0.05% | +620,351 | New | +$749K |
|
|
AGEN
15
Agenus
AGEN
$133M
| $635K | 0.04% | +231,663 | New | +$635K |
|
|
KRON
16
DELISTED
Kronos Bio
KRON
| $179K | 0.01% | +188,567 | New | +$179K |
|